Tags

, , , ,

Todd ReitzelBy Todd Reitzel

What’s your vision for what pharmaceutical science will offer public health over the next 20 years? Today’s news headlines include allegations of price gougingsettlements of Medicaid overcharging, mergers, and layoffs. But we know that pharmaceutical science is about so much more than that. In recent years, pharmaceutical scientists have developed more effective HIV cocktails, targeted cancer therapies, an HPV vaccine, and longer-lasting birth control.

What are the opportunities in coming years? Unmet medical needs constitute a much discussed topic, starting with a challenge issued by researchers from the Tufts Center for the Study of Drug Development. The American Association of Pharmaceutical Scientists (AAPS) has also been focusing on this. In June, the AAPS Newsmagazine surveyed four key areas of unmet needs. And at last month’s 2015 AAPS Annual Meeting and Exposition, attendees listened to three speakers share their perspectives.

The AAPS Blog now continues shutterstock_251431492the conversation with perspectives this week on three other potential areas of advancement: neurological cancers, mental illness, and chronic pain.

What’s your vision for pharmaceutical science in the next 20 years? Read the AAPS Blog this week. Comment on the posts. And send us your contribution!

TODD REITZEL, AAPS Director of publications, joined the aaps staff in 2012 with 20 years’ experience in scholarly and scientific publishing and a keen interest in Web publishing and electronic learning.